<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01834989</url>
  </required_header>
  <id_info>
    <org_study_id>H-4-2012-078</org_study_id>
    <nct_id>NCT01834989</nct_id>
  </id_info>
  <brief_title>Patellar Tendinopathy - Effect of Training and Enhancement of the Collagen Synthesis by Insulin-like Growth Factor-I</brief_title>
  <acronym>IGF-I</acronym>
  <official_title>Effect of Training and Local Infusion of Insulin-like Growth Factor-I and Training on Tendon Structure in Patients With Patellar Tendinopathy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Bispebjerg Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>The Danish Medical Research Council</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Bispebjerg Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of the study is to test the hypothesis that stimulation of the synthesis of new
      structural tendon proteins combined with training improve the tendon structure in patients
      with chronic knee tendon pain.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Randomized controlled intervention study: 12 weeks intervention period with training and
      injections of saline or Insulin-Like growth factor I. One year follow-up
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">April 2013</start_date>
  <completion_date type="Anticipated">June 2018</completion_date>
  <primary_completion_date type="Actual">February 1, 2017</primary_completion_date>
  <phase>Early Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Tendon structure</measure>
    <time_frame>After 12 weeks intervention (tendon biopsy)</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Tendon Pain</measure>
    <time_frame>1 year (before and after 12 weeks intervention and 1 year after intervention start)</time_frame>
    <description>questionnaire</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">40</enrollment>
  <condition>Tendinopathy</condition>
  <arm_group>
    <arm_group_label>Insulin-like growth factor I</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>3 injection (1 mg), once a week the first 3 weeks of the 12 weeks of intervention</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo injections</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>3 Injections of saline into the patellar tendon 3 times during the first 3 weeks of the 12 weeks interventions period</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Insulin-like growth factor I</intervention_name>
    <arm_group_label>Insulin-like growth factor I</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <arm_group_label>Placebo injections</arm_group_label>
    <other_name>Saline Injections</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  chronic patellar tendinopathy (&gt; 3 months)

          -  anterior-posterior thickening of the tendon (1 mm compared to mid-tendon)

          -  hypo-echoic area with enhanced vascularization

        Exclusion Criteria: injection

          -  corticosteroid injection within the last 12 months

          -  Knee operation

          -  Knee osteoarthritis

          -  Diabetes

          -  Smoking

          -  Body mass index &gt;30
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Michael Kjaer, Professor</last_name>
    <role>Principal Investigator</role>
    <affiliation>Institute of Sports Medicine, Copenhagen, Bispebjerg Hospital, 2400 Copenhagen, Denmark</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Mette Hansen, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Section of Sport Science, Department of Public Health, Aarhus University, Dalgas Avenue 4, 8000 Aarhus C, Denmark</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Jens Olesen, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Institute of Sports Medicine, Copenhagen, Bispebjerg Hospital, 2400 Copenahagen, Denmark</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Institute of Sports Medicine, Copenhagen</name>
      <address>
        <city>Copenhagen</city>
        <zip>2400</zip>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <link>
    <url>http://www.ismc.dk</url>
    <description>Study location</description>
  </link>
  <verification_date>February 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 16, 2013</study_first_submitted>
  <study_first_submitted_qc>April 16, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 18, 2013</study_first_posted>
  <last_update_submitted>February 7, 2017</last_update_submitted>
  <last_update_submitted_qc>February 7, 2017</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 9, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Bispebjerg Hospital</investigator_affiliation>
    <investigator_full_name>Mette Hansen</investigator_full_name>
    <investigator_title>Associated Professor, PhD</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Tendinopathy</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Insulin, Globin Zinc</mesh_term>
    <mesh_term>Insulin</mesh_term>
    <mesh_term>Mitogens</mesh_term>
    <mesh_term>Complement Factor I</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

